News
ALIPANC researchers conducted a study that links venous thromboembolic disease (VTE) with poorer survival in pancreatic cancer patients
The group led by Andrés Muñoz (Gregorio Marañón Hospital, Madrid) has published a subanalysis of the ONCOTHROMB12-01...
Pancreatic Cancer Conference, London 2026 – Cancer Research UK
Registration is now open for the Pancreatic Cancer Conference organised by Cancer Research UK. The event will take...
ALPANC researchers publish study protocol comparing 3D modeling versus conventional CT
3D-PANC study protocol: Is three-dimensional imaging technology superior to computed tomography for assessing the...
New potential therapeutic target for pancreatic cancer identified by ALIPANC researchers
The study by Parejo-Alonso et al. identifies PPAR-δ as a critical transcription factor mediating pancreatic cancer...
ALIPANC researchers develop a new therapeutic combination in preclinical models of pancreatic cancer.
This study conducted by researchers from Vigo presents an innovative sequential therapeutic strategy against...
Merry Christmas!
GNAS-ddPCR: A Cost-Effective First Step in the Diagnosis of Pancreatic Cystic Neoplasms, Developed by Researchers from the ALIPANC Group
The analysis of GNAS mutations using ddPCR in fluid obtained through endoscopic ultrasound–guided fine-needle...
Researchers from ALIPANC describe a triple therapy targeting key proteins in KRAS signaling that induces complete tumor regression in a mouse model
A study led by the Experimental Oncology Group at the Spanish National Cancer Research Centre (CNIO) has described a...
ALIPANC Election Results
On December 2, 2025, ALIPANC held its Extraordinary General Assembly to ratify the results of the electoral process...
IV ALIPANC Solidarity Gala Dinner: Science and Solidarity Against Pancreatic Cancer
On November 21, ALIPANC held its 4th Solidarity Gala Dinner at the Élkar restaurant in Madrid, coinciding with World...